Index.php - ReBorn Innovative Non-Invasive Fat Reduction Continues Global Expansion With Entry Into the Asia-Pacific Market.

Lightfective, a leading innovator of professional medical-aesthetic devices powered by its patented POWER LED technology is continuing the global expansion of its flagship ReBorn product for non-invasive fat reduction. Following its rapid expansion across Europe, ReBorn has successfully been launched in Australia, following regulatory clearance from the TGA (Therapeutic Goods Administration).

 

“The entry into Asia Pacific is a strategic move for ReBorn, as this market is one of the most advanced and innovative in terms of aesthetic treatments and rapid adoption of new technologies”, said Tsvi Bahat, Lightfective’s CEO and a veteran of the medical-aesthetic device industry. “Our initial expansion across Europe was aimed at launching ReBorn and making sure we deliver on our promise of top-notch results. Following the excellent outcome our customers have been achieving with ReBorn thus far, we felt it was time to expand further. Asia-Pacific is an important region in the beauty and aesthetic market, known to be early adapters and quick to implement new technologies. It has also been hit less significantly by COVID-19, compared to some of the other regions that possess a bigger challenge for new product introduction at this point in time”.

 

“ReBorn is a technological breakthrough, harnessing a new light-based power source (POWER LED) that provides several distinct competitive advantages and enhances the outcome of treatments”, said Bahat. “It is a great fit for the Asia Pacific market, which is always open to innovation and new technologies that deliver cutting edge results”.

To provide the necessary service and support in order to expand into the Australian market, Lightfective has teamed up with The Global Beauty Group in Australia as its local partner. According to Bahat, “the Global Beauty Group is one of Australia’s leading providers of cutting edge medical-aesthetic technologies and solutions to a broad range of clinics, spas and saloons. We are extremely delighted to be working with them on delivering the ReBorn promise to the local market”.

ABOUT LIGHTFECTIVE

Lightfective is a new and rapidly growing player in the field of light-based medical aesthetic devices, with a game-changing technology. This medical and aesthetic technology innovator was founded by seasoned entrepreneurs and engineers with a proven track record of success who have already established and led highly successful medical-aesthetic device companies in the past. The company is dedicated to optimizing its patented Power LED technology – which is poised to become the new gold standard for professional, constant-energy, light-based medical treatments.

ReBorn, the first device in a line of professional solutions being developed by the company, signals a true revolution in non-invasive fat reduction.

 

ABOUT THE GLOBAL BEAUTY GROUP

The Global Beauty Group delivers over 25 results driven technologies to more than 3,200 beauty businesses across Australia, New Zealand and the USA. With award-winning customer support, innovative face-to-face and online training programs, included marketing resources plus ongoing clinical and technical assistance, The Global Beauty Group strives to set new standards for excellence and live its mission of making people feel wonderful. The Global Beauty Group are 2018, 2019 and 2020 ABIA Wholesaler Of The Year winners, plus MyFaceMyBody winners for Distributor and Customer Support Of The Year.

Index.php - Our 2021 strategy – Lightfective

Lightfective is a new and rapidly growing player in the field of light-based medical aesthetic devices, with a game-changing technology. This medical and aesthetic technology innovator was founded by seasoned entrepreneurs and engineers with a proven track record of success who have already established and led highly successful medical-aesthetic device companies in the past.

 

Lightfective is dedicated to optimizing its patented Power LED technology – which is poised to become the new gold standard for professional, constant-energy, light-based medical treatments. The first in a planned line of professional solutions, the company’s ReBorn device signals a true revolution in non-invasive fat reduction.

 

Despite being the relatively “new kid” in the market, Lightfective has already begun to forge a strong name for its offering in the initial markets it has entered. Tsvi Bahat, Lightfective’s CEO, elaborates about the company’s business strategy as it sets out to become a significant player in its field.

 

According to Bahat, ReBorn was designed for professionals and uses major leaps in LED technology to provide a safe and versatile light source for uniform, highly efficient energy-based treatments. This innovative technology is optimal for non-invasive fat reduction and has already. Despite turbulent COVID-19 times, achieved a significant amount of very positive results and a growing base of satisfied customers.

 

Science and technology are at the heart of Lightfective’s corporate DNA. A major pillar of the company’s values and strategy is the thrive to develop cutting edge solutions that provide superb results. And so far, ReBorn is living up to this goal. The results the company is seeing from the growing number of patients that are undergoing ReBorn treatments are consistent and highly satisfying.

 

Bahat says that building a top-notch system is one of the company’s main areas of focus, but not the only one. In addition to improving the lives of consumers, part of Lightfective’s strategy is deeply committed to the success of its partners, providing not only the best-engineered device on the market, but also support throughout the device’s lifecycle – from financing, through marketing, to ongoing technical service.

 

To achieve its goals, Lightfective is utilizing a tried and tested strategy that has been successfully proven and validated by the company’s seasoned management team in previous ventures. The company began its initial launch in the European market, building on a combination of its strong network of partners, previous experience in the market, the ability to leverage the single CE approval required for multiple countries, and the close geographic proximity to the company’s HQ. This enabled Lightfective to provide strong clinical, technological and technical support to its partners and clients through the initial launch of ReBorn.

The company has already launched ReBorn in France, Italy, the UK and is in the process of entering other European markets.

In parallel, the company also launched the product in Israel. Israel provides a significant advantage in this field as it is a very mature and competitive market with a high level of solutions and services. This makes it an ideal launching ground for products like ReBorn in order to gain expert knowledge and insights, as well as adjust, modify and improve the product as needed based on the data and insights collected.

 

Setting the Infrastructure for rapid future expansion

Lightfective is currently in various stages of studies and regulatory processes that are required to launch ReBorn in key international markets.

In Asia-Pacific, the company has recently passed regulatory hurdles for its first markets – Singapore and Australia, with other markets to follow shortly. Asia-Pacific is an important region in the beauty and aesthetic market, known to be early adapters and quick to implement new technologies. It has also been hit less significantly by COVID-19, compared to some of the other regions that possess a bigger challenge for new product introduction at this point in time.

 

Finally, Lightfective is in the process of clinical studies for FDA approval, in order to be able to enter the North American market. The company has already obtained all regulatory authorization required and is deep in the process. Lightfective expects to launch ReBorn in the USA during 2022.

 

In summary, as evident from the above, Lightfective is moving forward rapidly to spread the ReBorn message around the world and offer its customers and partners the latest cutting edge technology in fat reduction.

 

 

Index.php - Our 2021 strategy – Lightfective

Lightfective is a new and rapidly growing player in the field of light-based medical aesthetic devices, with a game-changing technology. This medical and aesthetic technology innovator was founded by seasoned entrepreneurs and engineers with a proven track record of success who have already established and led highly successful medical-aesthetic device companies in the past.

Lightfective is dedicated to optimizing its patented Power LED technology – which is poised to become the new gold standard for professional, constant-energy, light-based medical treatments. The first in a planned line of professional solutions, the company’s ReBorn device signals a true revolution in non-invasive fat reduction.

Despite being the relatively “new kid” in the market, Lightfective has already begun to forge a strong name for its offering in the initial markets it has entered. Tsvi Bahat, Lightfective’s CEO, elaborates about the company’s business strategy as it sets out to become a significant player in its field.

According to Bahat, ReBorn was designed for professionals and uses major leaps in LED technology to provide a safe and versatile light source for uniform, highly efficient energy-based treatments. This innovative technology is optimal for non-invasive fat reduction and has already. Despite turbulent COVID-19 times, achieved a significant amount of very positive results and a growing base of satisfied customers.

Science and technology are at the heart of Lightfective’s corporate DNA. A major pillar of the company’s values and strategy is the thrive to develop cutting edge solutions that provide superb results. And so far, ReBorn is living up to this goal. The results the company is seeing from the growing number of patients that are undergoing ReBorn treatments are consistent and highly satisfying.

Bahat says that building a top-notch system is one of the company’s main areas of focus, but not the only one. In addition to improving the lives of consumers, part of Lightfective’s strategy is deeply committed to the success of its partners, providing not only the best-engineered device on the market, but also support throughout the device’s lifecycle – from financing, through marketing, to ongoing technical service.

 

To achieve its goals, Lightfective is utilizing a tried and tested strategy that has been successfully proven and validated by the company’s seasoned management team in previous ventures. The company began its initial launch in the European market, building on a combination of its strong network of partners, previous experience in the market, the ability to leverage the single CE approval required for multiple countries, and the close geographic proximity to the company’s HQ. This enabled Lightfective to provide strong clinical, technological and technical support to its partners and clients through the initial launch of ReBorn.

 

The company has already launched ReBorn in France, Italy, the UK and is in the process of entering other European markets.

 

In parallel, the company also launched the product in Israel. Israel provides a significant advantage in this field as it is a very mature and competitive market with a high level of solutions and services. This makes it an ideal launching ground for products like ReBorn in order to gain expert knowledge and insights, as well as adjust, modify and improve the product as needed based on the data and insights collected.

 

Setting the Infrastructure for rapid future expansion

Lightfective is currently in various stages of studies and regulatory processes that are required to launch ReBorn in key international markets.

In Asia-Pacific, the company has recently passed regulatory hurdles for its first markets – Singapore and Australia, with other markets to follow shortly. Asia-Pacific is an important region in the beauty and aesthetic market, known to be early adapters and quick to implement new technologies. It has also been hit less significantly by COVID-19, compared to some of the other regions that possess a bigger challenge for new product introduction at this point in time.

 

Finally, Lightfective is in the process of clinical studies for FDA approval, in order to be able to enter the North American market. The company has already obtained all regulatory authorization required and is deep in the process. Lightfective expects to launch ReBorn in the USA during 2022.

 

In summary, as evident from the above, Lightfective is moving forward rapidly to spread the ReBorn message around the world and offer its customers and partners the latest cutting edge technology in fat reduction.

 

 

Index.php - New Report by ResearchAndMarkets.com further highlights the strong growth of the Non-Invasive Fat Reduction Market

The Global Non-Invasive Fat Reduction Market Size, estimated to be USD 1.1Bn in 2020, is expected to enjoy a very strong CAGR of 15.2% and double in size to USD 2.2Bn by 2025, according to a new report by ResearchAndMarkets.com.

According to the report, increasing demand for body contouring treatments, along with a rise in the health care expenditure and a growingly inactive lifestyle are the key factors boosting the growth of the market for non-invasive fat reduction. This treatment segment is expected to be one of the fastest growing and most popular aesthetic procedures over the next several years.

The market growth is expected to be further fueled by a rise in disposable Income and consumer spending following growth outlook in the global economy in the wake of the COVID 19 pandemic. Another main drive is a constant increase in adoption of non-invasive treatments.

Within this market, Lightfective’s innovative ReBorn technology is well positioned to capitalize on the accelerated growth outlook. Offering an innovative approach to noninvasive fat reduction with several unique benefits and a very strong business case and ROI, ReBorn is steadily gaining ground as new territories and new customers are constantly being onboarded.

Read the original article here

 

 

For more information about ReBorn contact us at info@lightfective.com 

 

ReBorn is deeply committed to promoting our clients’ practices and reputations. Our ever-expanding support network is here to meet your needs.